Core Laboratories Inc. (NYSE:CLB) Stock Holdings Lifted by Boston Trust Walden Corp

Boston Trust Walden Corp grew its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 2.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 617,336 shares of the oil and gas company's stock after buying an additional 16,503 shares during the period. Boston Trust Walden Corp owned 1.31% of Core Laboratories worth $10,686,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Disciplined Growth Investors Inc. MN raised its stake in Core Laboratories by 26.7% in the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 5,653,591 shares of the oil and gas company's stock valued at $104,761,000 after purchasing an additional 1,192,871 shares during the last quarter. State Street Corp grew its holdings in shares of Core Laboratories by 2.9% during the third quarter. State Street Corp now owns 1,975,016 shares of the oil and gas company's stock worth $36,597,000 after buying an additional 56,187 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Core Laboratories by 0.7% in the third quarter. Geode Capital Management LLC now owns 1,053,204 shares of the oil and gas company's stock valued at $19,521,000 after buying an additional 7,721 shares during the last quarter. Royce & Associates LP lifted its stake in shares of Core Laboratories by 9.0% during the third quarter. Royce & Associates LP now owns 1,021,121 shares of the oil and gas company's stock valued at $18,921,000 after buying an additional 84,022 shares during the period. Finally, Fisher Asset Management LLC boosted its position in Core Laboratories by 19.5% during the third quarter. Fisher Asset Management LLC now owns 990,267 shares of the oil and gas company's stock worth $18,350,000 after acquiring an additional 161,278 shares during the last quarter. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have weighed in on CLB. StockNews.com upgraded Core Laboratories from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Citigroup dropped their target price on Core Laboratories from $15.00 to $14.00 and set a "sell" rating for the company in a research note on Thursday, October 31st. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $17.00.

Core Laboratories Trading Down 0.5 %

CLB stock traded down $0.09 on Friday, hitting $16.61. 302,016 shares of the company were exchanged, compared to its average volume of 311,125. The stock has a market capitalization of $779.89 million, a price-to-earnings ratio of 25.17, a price-to-earnings-growth ratio of 0.99 and a beta of 2.38. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.32 and a quick ratio of 1.71. The business's fifty day moving average is $18.50 and its two-hundred day moving average is $19.21. Core Laboratories Inc. has a twelve month low of $13.82 and a twelve month high of $25.13.

Core Laboratories (NYSE:CLB - Get Free Report) last released its quarterly earnings data on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share for the quarter, meeting the consensus estimate of $0.23. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. As a group, research analysts forecast that Core Laboratories Inc. will post 0.96 earnings per share for the current year.

Core Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Monday, February 10th will be paid a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.24%. The ex-dividend date of this dividend is Monday, February 10th. Core Laboratories's dividend payout ratio is presently 6.06%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.